GCG and Insulin resistance: We hypothesize that sitagliptin is able to preserve pancreatic function by improving insulin resistance and by other cytoprotective properties, including antiapoptotic, anti-inflammatory and pro-proliferative, based on the cytoprotective properties previously reported for incretin peptides in distinct tissues [29,37-43].